AOD-9604 is a modified fragment of human growth hormone (hGH) that specifically targets fat metabolism without the anabolic or diabetogenic effects of full HGH.
Stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation) through direct activation of beta-3 adrenergic receptors in adipose tissue.
Generally well-tolerated. Minor injection site reactions possible. Does not affect blood glucose or IGF-1 levels.
Inject 500 mcg SubQ once daily on an empty stomach, preferably in the morning or before exercise.